Motley Fool Wealth Management LLC Has $2.83 Million Stock Position in The Procter & Gamble Company (NYSE:PG)

Motley Fool Wealth Management LLC lowered its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 18.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 19,205 shares of the company’s stock after selling 4,311 shares during the quarter. Motley Fool Wealth Management LLC’s holdings in Procter & Gamble were worth $2,825,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Cerity Partners LLC raised its stake in Procter & Gamble by 106.2% during the 4th quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock worth $898,943,000 after buying an additional 3,159,796 shares during the period. Wellington Management Group LLP raised its stake in Procter & Gamble by 9.4% during the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after buying an additional 3,047,557 shares during the period. International Assets Investment Management LLC raised its stake in Procter & Gamble by 13,850.3% during the 4th quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock worth $402,601,000 after buying an additional 2,727,685 shares during the period. Assenagon Asset Management S.A. raised its stake in Procter & Gamble by 235.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock worth $473,475,000 after buying an additional 2,268,805 shares during the period. Finally, J.P. Morgan Private Wealth Advisors LLC acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $246,412,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE PG traded down $1.26 during midday trading on Friday, reaching $161.29. 5,659,784 shares of the company were exchanged, compared to its average volume of 6,820,118. The stock’s 50-day moving average price is $159.64 and its 200-day moving average price is $153.51. The stock has a market cap of $380.67 billion, a P/E ratio of 26.35, a PEG ratio of 3.30 and a beta of 0.44. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. During the same quarter in the previous year, the firm posted $1.37 earnings per share. The company’s revenue was up .6% on a year-over-year basis. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares in the company, valued at $1,858,265.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now owns 36,845 shares in the company, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 100,865 shares of company stock valued at $16,029,280. 0.17% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have issued reports on the company. Argus lifted their price target on Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday. UBS Group raised their price objective on Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and raised their price objective for the company from $160.00 to $175.00 in a report on Monday, March 11th. Wells Fargo & Company raised their price objective on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a report on Wednesday, January 24th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $169.76.

Read Our Latest Research Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.